We observed that pharmacological inhibition with MKC8866 an inhibitor of IRE1α endoribonuclease35 significantly reduced levels of Xbp1s and its canonical targets in the lung, however, treatment of HKP1-bearing mice failed to control tumor progression (data not shown). The gene discussed is TFB2M; the disease is neoplasm.